Literature DB >> 28481354

Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore.

M B Abid1, D Christopher2, M A Abid3, M L Poon1, L K Tan1, L P Koh1, W J Chng1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28481354     DOI： 10.1038/bmt.2017.77

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  Outcome disparities in multiple myeloma: a SEER-based comparative analysis of ethnic subgroups.

Authors:  Sikander Ailawadhi; Ibrahim T Aldoss; Dongyun Yang; Pedram Razavi; Wendy Cozen; Taimur Sher; Asher Chanan-Khan
Journal:  Br J Haematol       Date:  2012-04-26       Impact factor: 6.998

2.  Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

Authors:  Mohamed L Sorror; Michael B Maris; Rainer Storb; Frederic Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Journal:  Blood       Date:  2005-06-30       Impact factor: 22.113

3.  International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation.

Authors:  Michele Cavo; S Vincent Rajkumar; Antonio Palumbo; Philippe Moreau; Robert Orlowski; Joan Bladé; Orhan Sezer; Heinz Ludwig; Meletios A Dimopoulos; Michel Attal; Pieter Sonneveld; Mario Boccadoro; Kenneth C Anderson; Paul G Richardson; William Bensinger; Hans E Johnsen; Nicolaus Kroeger; Gösta Gahrton; P Leif Bergsagel; David H Vesole; Hermann Einsele; Sundar Jagannath; Ruben Niesvizky; Brian G M Durie; Jesus San Miguel; Sagar Lonial
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

4.  Outpatient Autologous Stem Cell Transplantation for Patients With Myeloma.

Authors:  Thomas M Paul; Stephen V Liu; Elise A Chong; Selina M Luger; David L Porter; Stephen J Schuster; Donald E Tsai; Sunita D Nasta; Alison Loren; Noelle Frey; Alexander Perl; Adam D Cohen; Brendan M Weiss; Edward A Stadtmauer; Dan T Vogl
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

5.  Safety of outpatient autologous hematopoietic cell transplantation for multiple myeloma and lymphoma.

Authors:  T M Graff; A K Singavi; W Schmidt; D Eastwood; W R Drobyski; M Horowitz; J Palmer; M Pasquini; D J Rizzo; W Saber; P Hari; T S Fenske
Journal:  Bone Marrow Transplant       Date:  2015-04-13       Impact factor: 5.483

6.  Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.

Authors:  Andreas Holbro; Imran Ahmad; Sandra Cohen; Jean Roy; Silvy Lachance; Miguel Chagnon; Richard LeBlanc; Lea Bernard; Lambert Busque; Denis Claude Roy; Guy Sauvageau; Thomas L Kiss
Journal:  Biol Blood Marrow Transplant       Date:  2012-12-16       Impact factor: 5.742

7.  Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative.

Authors:  Morie A Gertz; Stephen M Ansell; David Dingli; Angela Dispenzieri; Francis K Buadi; Michelle A Elliott; Dennis A Gastineau; Suzanne R Hayman; William J Hogan; David J Inwards; Patrick B Johnston; Shaji Kumar; Martha Q Lacy; Nelson Leung; Ivana N M Micallef; Luis F Porrata; Barbara A Schafer; Robert C Wolf; Mark R Litzow
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

8.  Recent improvement in survival of patients with multiple myeloma: variation by ethnicity.

Authors:  Dianne Pulte; Maria Theresa Redaniel; Hermann Brenner; Lina Jansen; Mona Jeffreys
Journal:  Leuk Lymphoma       Date:  2013-09-03

9.  Superiority of bortezomib, thalidomide, and dexamethasone (VTD) as induction pretransplantation therapy in multiple myeloma: a randomized phase 3 PETHEMA/GEM study.

Authors:  Laura Rosiñol; Albert Oriol; Ana Isabel Teruel; Dolores Hernández; Javier López-Jiménez; Javier de la Rubia; Miquel Granell; Joan Besalduch; Luis Palomera; Yolanda González; María Asunción Etxebeste; Joaquín Díaz-Mediavilla; Miguel T Hernández; Felipe de Arriba; Norma C Gutiérrez; María Luisa Martín-Ramos; María Teresa Cibeira; María Victoria Mateos; Joaquín Martínez; Adrián Alegre; Juan José Lahuerta; Jesús San Miguel; Joan Bladé
Journal:  Blood       Date:  2012-07-12       Impact factor: 22.113

Review 10.  Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.

Authors:  M Martino; R M Lemoli; C Girmenia; L Castagna; B Bruno; F Cavallo; M Offidani; I Scortechini; M Montanari; G Milone; L Postacchini; A Olivieri
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483
View more
  3 in total

1.  Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors.

Authors:  Jane Koo; Stacy Silverman; Brandon Nuechterlein; Amy K Keating; Michael R Verneris; Nicholas K Foreman; Jean M Mulcahy Levy
Journal:  Bone Marrow Transplant       Date:  2019-02-19       Impact factor: 5.483

Review 2.  Multiple Myeloma Outpatient Transplant Program in the Era of Novel Agents: State-of-the-Art.

Authors:  Massimo Martino; Annalisa Paviglianiti; Mara Memoli; Giovanni Martinelli; Claudio Cerchione
Journal:  Front Oncol       Date:  2020-11-11       Impact factor: 6.244

3.  Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis.

Authors:  Weerapat Owattanapanich; Kittima Suphadirekkul; Chutima Kunacheewa; Patompong Ungprasert; Kannadit Prayongratana
Journal:  BMC Cancer       Date:  2018-11-16       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.